DOCS NYSE
Doximity, Inc.
1W: +6.0%
1M: +6.1%
3M: +22.2%
YTD: -35.5%
1Y: -60.5%
3Y: +35.3%
5Y: -67.6%
$27.93
-0.57 (-2.00%)
Weekly Expected Move ±6.7%
$24
$26
$28
$30
$32
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.00
Neutral
1 bullish
0 neutral
1 bearish
Articles (7d)
2
Daily Sentiment (7 Days)
Articles (100)
Doximity (DOCS) Gains As Market Dips: What You Should Know
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS
Doximity (DOCS) Surpasses Market Returns: Some Facts Worth Knowing
Brokerages Set Doximity, Inc. (NYSE:DOCS) Target Price at $32.18
Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Note
Neuraxis Gains Nearly 137% in a Year: What's Driving the Stock?
Doximity falls as Freedom Capital downgrades on revised EBITDA outlook
32,613 Shares in Doximity, Inc. $DOCS Purchased by AlphaGrep UK Ltd
AXQ Capital LP Has $3.67 Million Stake in Doximity, Inc. $DOCS
Reasons to Retain Doximity Stock in Your Portfolio for Now
HIMS Stock More Than Doubled in 6 Months: What's Driving the Rally?
A Doximity Director Moved 7,500 Shares the Day the Stock Popped 33%. Here's What to Know
What Investors Should Know of This Doximity Officer's Latest Insider Transaction
Doximity Handed Its President 150,000 Options Last Month. Here's What the Latest Filing Signals for Investors
Doximity's New CFO Just Filed His First Form 4. Here's What Long-Term Investors Should Know.
Doximity's Co-Founder Just Filed a Form 4. Is There Anything in It Worth Worrying About?
Doximity (DOCS) Q1 2027 Earnings Call Transcript
Atlassian and Doximity Just Surged 30% After Earnings: 3 Software Stocks with the Same Setup
Doximity Shares (NYSE:DOCS) Gain Around $1.2 Billion as Market Values Exceed Forecasts - TechStock²
Doximity (DOCS) Stock Fair Value Rises After Split Analyst Views On AI Growth
Doximity (DOCS) Stock Fair Value Rises After Split Analyst Views On AI Growth - Yahoo Finance
Doximity, Inc. $DOCS Shares Purchased by Quantinno Capital Management LP - MarketBeat
Doximity (DOCS) Is Up 31.0% After Raising Revenue Outlook On Clinical AI Adoption - Has The Bull Case Changed?
Doximity (DOCS) Is Up 31.0% After Raising Revenue Outlook On Clinical AI Adoption - Has The Bull Case Changed? - Yahoo Finance
Why Doximity Stock Skyrocketed on Friday
Why Doximity Stock Skyrocketed on Friday - Yahoo Finance
Why Doximity Stock Skyrocketed on Friday
Doximity: I Called The Pop Over A Month Ago, But Now Is The Time To Wait (Rating Downgrade) - Seeking Alpha
Doximity (DOCS) Stock Jumps As AI Adoption Lifts Profit Confidence - simplywall.st
Doximity Q1 Earnings Call Highlights
Why Doximity Stock Is Soaring 38% After an Earnings Miss
Why Doximity Stock Is Up 80% - Yahoo Finance
Why Doximity Stock Is Up 80%
DOCS Stock Surges 40% Following Doximity Earnings. What Comes Next. - Yahoo Finance
DOCS Stock Surges 40% Following Doximity Earnings. What Comes Next.
Doximity Stock Explodes 52.7% as Clinical AI Engagement Accelerates
DOCS Q1 Earnings Miss on Higher AI Costs, Revenues Beat, FY27 View Up
DOCS Q1 Earnings Miss on Higher AI Costs, Revenues Beat, FY27 View Up - Yahoo Finance
DOCS Q1 Earnings Miss on Higher AI Costs, Revenues Beat, FY27 View Up
Doximity Raises FY27 Outlook on AI Search Momentum, RBC Says
Here’s Why Doximity Stock Is Flying Today
Here’s Why Doximity Stock Is Flying Today - Investopedia
Why Did Doximity (DOCS) Stock Rocket Despite Mixed Q1 Earnings? - TipRanks
'LinkedIn for Doctors' Stock Nearly Doubles After Earnings - schaeffersresearch.com
Doximity Jumps On Earnings: Explaining The Outsized Stock Move (Rating Upgrade) (DOCS) - Seeking Alpha
Doximity Shares Soar After Revenue Beat and Higher Full-Year Forecast - Yahoo Finance
Doximity Shares Soar After Revenue Beat and Higher Full-Year Forecast
Doximity, Cloudflare and Atlassian surge premarket
Doximity, Inc. Q1 2027 Earnings Call Summary
DOCS Stock Soars After CEO Says Clinical AI Outperformed Anthropic, Wall Street Lifts Price Targets
DOCS Stock Soars After CEO Says Clinical AI Outperformed Anthropic, Wall Street Lifts Price Targets - stocktwits.com
Doximity signals FY2027 revenue of $671M-$681M while expanding AI investment with 165 signed health system AI clients
Doximity (DOCS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Doximity (DOCS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Doximity (DOCS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Doximity (DOCS) Q1 Earnings Lag Estimates
Doximity (DOCS) Q1 Earnings Lag Estimates
Doximity’s (NYSE:DOCS) Q2 CY2026: Beats On Revenue
Ahead of Doximity (DOCS) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Doximity (DOCS) Stock May Be 41% Undervalued As Cash Flow Holds Up - Yahoo Finance
Doximity (DOCS) Laps the Stock Market: Here's Why
California Public Employees Retirement System Raises Stock Holdings in Doximity, Inc. $DOCS
Doximity (DOCS) Declines More Than Market: Some Information for Investors
Reasons to Retain Doximity Stock in Your Portfolio for Now
Seeking Alpha’s Quant Spotlight: Highest and lowest rated healthcare stocks ahead of Q2
Doximity (DOCS) Stock Declines While Market Improves: Some Information for Investors
Doximity (DOCS) Stock Moves 1.25%: What You Should Know
Doximity (DOCS) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Doximity (DOCS) Advances While Market Declines: Some Information for Investors
Doximity (DOCS) Up 11.2% Since Last Earnings Report: Can It Continue?
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Doximity, Inc. – DOCS
OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?
Doximity: A Strong Contender or Vulnerable to Disruption?
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS
Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale?
OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?
OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds
Notable analyst calls this week: Dell, J&J and AMD stocks among top picks
Nasdaq 100 Drops, Intel Crashes 7% On Rate-Hike Panic: Stock Market Today
DOCS vs. HIMS: Which Stock Is the Better Value Option?
DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based Care
HIMS Stock Dips 14.3% Since Q1 Earnings: Should You Still Hold or Sell?
Gemini Space Posts Upbeat Q1 Results, Joins Figma, Sutro Biopharma And Other Big Stocks Moving Higher On Friday
OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead?
Down 25.7% in 4 Weeks, Here's Why Doximity (DOCS) Looks Ripe for a Turnaround
Doximity Sinks 24% As AI Push Fails To Ease Growth Fears
Doximity Flags Pharma Ad Market Weakness
Doximity Stock Falls on Q4 Earnings Miss, Revenues Beat, Margins Down
Why Doximity Stock Plunged Today
These Analysts Slash Their Forecasts On Doximity After Q4 Results
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Doximity, Aeluma, PDF Solutions And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Stock Market Today: S&P 500, Dow Jones Futures Gain As Trump Clears NVDA's H200 Sales To China—Cisco Systems, Doximity, Grocery Outlet In Focus
Dillard's, Cisco Systems And 3 Stocks To Watch Heading Into Thursday
Doximity (DOCS) Q4 2026 Earnings Transcript
Doximity (DOCS) Lags Q4 Earnings Estimates
12 Health Care Stocks Moving In Wednesday's After-Market Session
Doximity Stock Dives On Q4 Earnings, Weak Outlook
Doximity Non-GAAP EPS of $0.26 misses by $0.02, revenue of $145.4M beats by $1.49M
Stock Market Today: Nasdaq 100 Rises Despite Hot PPI, Nvidia Hits Record High